Company / FCF Margin
RIGEL PHARMACEUTICALS INC FCF Margin History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-61.7%
FY2022
5-year range
-61.7% / 3.5%
FY2018-FY2022
Trend
-1853.4%
vs FY2021
Sector context
#83 of 133
Health Care
What the data says
FCF Margin changed -1853% YoY in FY2022, a notable deviation from the 4-year average annual change of -408%.
Based on SEC 10-K filings.
-61.7% in FY2022 with a 3-year CAGR of +10.8%.
Declined from -49.2% to -61.7% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +10.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#83 of 133 in Health CareTop 62% of 133This company -61.7% Sector average -632.8%
▼
+90.2% above sector average
Key checks
Key Insights
- In FY2022, fcf margin decreased 1853.4% year-over-year.
- Currently 571.1pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2021.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -61.7% | -1853.4% |
| FY2021 | 3.5% | +107.2% |
| FY2020 | -49.2% | +32.1% |
| FY2019 | -72.5% | +80.7% |
| FY2018 | -376.3% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026